Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results Director departure CC transcript Asset disposition Credit agrmnt [a] Appointed director Auditor change Inv. presentation
|
|
Teligent, Inc. (TLGT)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/31/2020 |
8-K
| Quarterly results |
| 08/19/2020 |
8-K
| Quarterly results |
| 05/22/2020 |
8-K
| Quarterly results |
| 04/08/2020 |
8-K
| Quarterly results |
| 11/04/2019 |
8-K
| Quarterly results |
| 08/05/2019 |
8-K
| Quarterly results |
| 05/06/2019 |
8-K
| Quarterly results |
| 03/18/2019 |
8-K
| Quarterly results |
| 08/08/2018 |
8-K
| Quarterly results |
| 05/08/2018 |
8-K
| Quarterly results |
| 03/15/2018 |
8-K
| Quarterly results |
| 11/06/2017 |
8-K
| Quarterly results |
| 08/08/2017 |
8-K
| Quarterly results |
| 05/10/2017 |
8-K/A
| Form 8-K/A - Current report [Amend] |
| 03/17/2017 |
8-K/A
| Form 8-K/A - Current report [Amend] |
| 03/07/2017 |
8-K
| Form 8-K - Current report |
| 10/27/2016 |
8-K
| Form 8-K - Current report |
| 07/28/2016 |
8-K
| Form 8-K - Current report |
| 04/28/2016 |
8-K
| Quarterly results |
| 03/09/2016 |
8-K
| Form 8-K - Current report |
| 10/22/2015 |
8-K
| Quarterly results |
| 07/23/2015 |
8-K
| Quarterly results |
| 04/28/2015 |
8-K
| Quarterly results |
| 03/02/2015 |
8-K
| Quarterly results|
Docs:
|
"IGI LABORATORIES ANNOUNCES FOURTH QUARTER and YEAR END 2014 RESULTS BUENA, NJ - – IGI Laboratories, Inc. , a New Jersey based specialty generic pharmaceutical company, announced its financial results for the fourth quarter and year ended December 31, 2014. Fourth Quarter and Year to Date 2014 Highlights · Total revenues of $13.7 million in the fourth quarter of 2014, an increase of 104% over the same quarter in 2013 · Total revenues of $33.7 million for the year ended December 31, 2014, an increase of 85% over the same period in 2013 · Total net revenues generated from the sale of IGI label generic topical pharmaceutical products for the three and twelve months ended December 31, 2014 of $10.5 million, and $19.8 million, respectively · Gross profit for the year ..." |
|
| 10/23/2014 |
8-K
| Quarterly results |
| 07/24/2014 |
8-K
| Quarterly results |
| 04/29/2014 |
8-K
| Quarterly results |
| 02/27/2014 |
8-K
| Quarterly results |
| 10/29/2013 |
8-K
| Form 8-K - Current report |
| 07/25/2013 |
8-K
| Quarterly results |
| 04/25/2013 |
8-K
| Form 8-K - Current report |
| 03/05/2013 |
8-K
| Form 8-K - Current report |
| 11/13/2012 |
8-K
| Form 8-K - Current report |
| 08/13/2012 |
8-K
| Form 8-K - Current report |
|
|
|